Hsu Jason 4
4 · Immix Biopharma, Inc. · Filed Aug 26, 2024
Insider Transaction Report
Form 4
Hsu Jason
Director
Transactions
- Purchase
Common Stock
2024-08-22$2.25/sh+8,100$18,233→ 845,300 total - Purchase
Common Stock
2024-08-21$2.23/sh+15,000$33,390→ 837,200 total
Holdings
- 50,000(indirect: See Footnote)
Common Stock
- 3,915,913(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $2.22 to $2.23, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $2.162 to $2.29, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Hsu disclaims beneficial ownership of the securities held by VERITAS LIBERABIT VOS, LLC, except to the extent of his pecuniary interest therein.
- [F4]Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Hsu disclaims beneficial ownership of the securities held by Signature Collection Properties, LLC, except to the extent of his pecuniary interest therein.